Company to Showcase Latest Version of MR Image Analysis Suite Along with New PowerLook Advanced Mammography Platform for First Time at RSNA "iCAD is committed to developing the most comprehensive, ...
Greetings and welcome to the iCAD Incorporated Fourth Quarter and Full Year 2023 Earnings Conference Call. At this time, all participants are on a listen-only mode, and a question-and-answer session ...
CHICAGO--(BUSINESS WIRE)--iCAD, Inc. (NASDAQ: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the identification and treatment of cancer, ...
NASHUA, N.H.--(BUSINESS WIRE)-- iCAD, Inc. (NAS: ICAD) , an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of ...
Greetings. Welcome to the iCAD Incorporated Third Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal ...
NASHUA, N.H., March 15, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that ...
NASHUA — U.S. Sen. Maggie Hassan, Democrat of New Hampshire, got a first-hand look Tuesday at new technology aimed at revolutionizing the breast-cancer screening and risk-assessment process during a ...
iCAD thinks it might have a technical solution that could greatly cut the cost of 3-D mammography in the United States. Buoyed by positive test results, the Nashua-based cancer provider of deduction ...
Shares of iCAD Inc. were indicated up over 30% in premarket trade Wednesday, after the provider of technology for use in cancer detection announced Food and Drug Administration clearance of its latest ...
Markets Insider and Business Insider Editorial Teams were not involved in the creation of this post. icad NewsMORE Related Stocks Indices Commodities Currencies Stocks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results